Sunday, October 26, 2014

Stellar Biotechnologies harvests mollusks for KLH protein

Stellar Biotechnologies harvests mollusks for KLH protein

October 21, 2014 by · Leave a Comment 

Tweet A mollusk living in the coastal waters off California from Monterey to the Baja Peninsula may hold the key to new therapies to treat cancer and autoimmune diseases. Stellar Biotechnologies (OTCQB:SBOTF; TSX-V:KLH) has pioneered technology to grow the mollusk, known as the Giant Keyhole Limpet, and produce and purify KLH, or keyhole limpet hemocyanin, […]

In conversation with Ron Babecoff

In conversation with Ron Babecoff

October 14, 2014 by · Leave a Comment 

Tweet As a co-founder of BiondVax Pharmaceuticals (TASE:BNDX), Ron Babecoff has led the Israeli developer of a universal flu vaccine since its inception in 2003. Prior to BiondVax, Dr. Babecoff was with Omrix Biopharmaceuticals as marketing manager, where he was involved in identifying West Nile Fever treatments and building cooperation with the NIH, and forming […]

How Itamar Medical’s PAT signal is improving health

How Itamar Medical’s PAT signal is improving health

October 7, 2014 by · Leave a Comment 

http://www.youtube.com/watch?v=rUgrv4arPdY’]

Tweet Using an unique and innovative technology known as peripheral arterial tone (PAT), Itamar Medical (TASE:ITMR) is detecting the functioning and health of arteries through a finger sensor for the diagnosis of sleep apnea and heart disease. “Our technology is a non-invasive measurement of changes in a patient’s pulsatile arterial volume that provides a window […]

In conversation with Pivotal Therapeutics

In conversation with Pivotal Therapeutics

September 30, 2014 by · Leave a Comment 

Tweet BioTuesdays.com recently sat down with the management team at Pivotal Therapeutics (OTCQX:PVTTF; CSE:PVO) to discuss the company’s VASCAZEN product that addresses Omega-3 deficiency in cardiovascular disease (CVD) patients, an under-recognized, yet highly prevalent condition. The team, including Eugene Bortoluzzi, CEO, Dr. George Jackowski, CSO, Rachelle MacSweeney, president & COO, and newly appointed CFO, Prakash […]

Amarantus on road to commercializing AD test

Amarantus on road to commercializing AD test

September 23, 2014 by · Leave a Comment 

Tweet Amarantus Bioscience Holdings’ (OTCQB:AMBS) master services agreement with the lab services arm of ICON (NASDAQ:ICLR) puts Amarantus on the road to commercializing its LymPro diagnostic blood test for the early detection of Alzheimer’s disease (AD). “This agreement represents a major milestone, as we can now prepare LymPro for launch with a top-tier commercial development […]

Cipher Pharma adopts 5-by-5 mantra for future growth

Cipher Pharma adopts 5-by-5 mantra for future growth

September 16, 2014 by · Leave a Comment 

Tweet Cipher Pharmaceuticals (OTCBB:CPHMF; TSX:DND), with newly installed CEO, Shawn O’Brien, has adopted a five-by-five strategy that sets objectives for its future growth. “I want to emphasize that this is not guidance, but within five years, we want our dermatology business in Canada to grow from $2-million this year to $50-million, we want to have […]

Continuum of care to drive future NOVADAQ imaging growth

Continuum of care to drive future NOVADAQ imaging growth

September 9, 2014 by · Leave a Comment 

Tweet NOVADAQ Technologies (NASDAQ:NVDQ; TSX:NDQ), pioneers in fluorescence imaging solutions for the operating room, is now focused on manufacturing and directly marketing and selling imaging solutions for use at multiple points throughout the patient care continuum. “Our continuum of care includes diagnostics that can be performed at outpatient clinics and by primary care physicians, where […]

Dipexium aims to have first topical antibiotic approved for DFI

Dipexium aims to have first topical antibiotic approved for DFI

September 2, 2014 by · Leave a Comment 

Tweet Dipexium (NASDAQ:DPRX) is enrolling patients in two pivotal Phase 3 trials of its Locilex topical antibiotic in what it hopes will be the first FDA-approved antibiotic topical cream for the treatment of mild infections of diabetic foot ulcers. “Current treatments used off-label to treat mild diabetic foot infections (DFI) generate systemic resistance, exhibit poor […]

Finding the origins of cancer with Rosetta Genomics

Finding the origins of cancer with Rosetta Genomics

August 26, 2014 by · Leave a Comment 

http://www.youtube.com/watch?v=z8RTk67NNWg’]

Tweet Taking its name from the Rosetta Stone, which paved the way to decipher ancient Egyptian hieroglyphics, Rosetta Genomics (NASDAQ:ROSG) is unlocking the relevance of microRNA within the human genome to develop next generation diagnostic tests for personalized medicine. “MicroRNAs are master gene regulators of almost every activity in the cell, and when something goes […]

Titan implanting treatments for opioid dependence

Titan implanting treatments for opioid dependence

August 19, 2014 by · Leave a Comment 

Tweet In the continuing struggle to circumvent abuse of drugs to treat opioid dependence and enhance compliance regimes for better outcomes, Titan Pharmaceuticals (OTCBB:TTNP) is leading the race with a matchstick-sized implant of the approved drug, buprenorphine, which eases withdrawal symptoms. “With more than two million people in the U.S. suffering from opioid dependence, there […]

Next Page »

Email Newsletters with Constant Contact
Google+